A Longitudinal Computed Tomography Study of Lenalidomide and Bortezomib Treatment for Multiple Myeloma: Trabecular Microarchitecture and Biomechanics Assessed Using Multidetector Computed Tomography.

CONCLUSION: Lenalidomide treatment resulted in significant increases in CT/FEM-derived estimates of bone strength. Response to chemotherapy predicted lenalidomide-induced bone changes and good responders had increased bone strength. PMID: 25190250 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/25190250?dopt=Abstract

Source: Clinical Lymphoma and Myeloma - August 12, 2014 Category: Cancer & Oncology Authors: Takasu M, Tani C, Kaichi Y, Sakoda Y, Kiguchi M, Date S, Kuroda Y, Sakai A, Awai K Tags: Clin Lymphoma Myeloma Leuk Source Type: research